Ignite Creation Date:
2024-05-06 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03512314
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-08
First Post:
2018-04-09
Brief Title:
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Sponsor:
AB2 Bio Ltd
Organization:
AB2 Bio Ltd
Organization Data
Organization:
AB2 Bio Ltd
Class:
INDUSTRY
Study ID:
OLE-NLRC4XIAP2016001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AB2 Bio Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None